Misbranded and Adulterated Drugs Nets Innovative Compounding Pharmacy Warning Letter

Drug Industry Daily
A A
The Innovative Compounding Pharmacy (ICP) has received a warning letter after an inspection revealed misbranded and adulterated drug products.

To View This Article:

Login

Subscribe To Drug Industry Daily